Lara Mott Co-Founded ImproveWell in 2016 to empower frontline healthcare professionals to drive change. ImproveWell’s digital platform aggregates data, completes feedback loops and facilitates shared knowledge. In less than three years, the technology is being used across the NHS, and in the USA and New Zealand. ImproveWell has also formed industry-leading partnerships with East London NHS Foundation Trust and UCL Partners Academic Health Science Network. In 2018, Lara secured over £400,000 in external investment and has since grown the team to eight members of staff.

Previously, Lara held various senior roles across healthcare specialist investment, biotech, life sciences consulting and financial services businesses. In 2014 she supported one of the largest UK biotech fundraisings at flotation on the London Stock Exchange, raising £200 million for Circassia, a specialty pharmaceutical company, and in 2016 she directed a €660 million healthcare private equity fundraise for GHO Capital. She was deputy chair of the UK BioIndustry Association Communications Advisory Committee for over four years, and was also a trustee for the award-winning international NGO, Selfless.

Lara holds a first class degree in pharmacology from Bristol University where she was awarded the Hans Heller Memorial Prize for outstanding performance. In November 2017 she was named a “rising star” among the top 50 female leaders in UK healthcare by BioBeat and in April 2019 she was appointed as BMJ’s first Entrepreneur in Residence.